Invesco’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $680K | Buy |
282,192
+40,495
| +17% | +$97.6K | ﹤0.01% | 3029 |
|
|
2025
Q1 | $534K | Buy |
241,697
+15,751
| +7% | +$34.8K | ﹤0.01% | 3110 |
|
|
2024
Q4 | $1.23M | Buy |
225,946
+17
| +0% | +$93 | ﹤0.01% | 2822 |
|
|
2024
Q3 | $1.88M | Sell |
225,929
-2,258
| -1% | -$18.8K | ﹤0.01% | 2624 |
|
|
2024
Q2 | $1.63M | Sell |
228,187
-411,779
| -64% | -$2.95M | ﹤0.01% | 2674 |
|
|
2024
Q1 | $5.55M | Buy |
639,966
+426,644
| +200% | +$3.7M | ﹤0.01% | 2167 |
|
|
2023
Q4 | $1.4M | Buy |
213,322
+55,575
| +35% | +$364K | ﹤0.01% | 2745 |
|
|
2023
Q3 | $1.58M | Sell |
157,747
-225,588
| -59% | -$2.26M | ﹤0.01% | 2677 |
|
|
2023
Q2 | $4.76M | Buy |
383,335
+29,674
| +8% | +$369K | ﹤0.01% | 2265 |
|
|
2023
Q1 | $4.95M | Sell |
353,661
-38,045
| -10% | -$533K | ﹤0.01% | 2220 |
|
|
2022
Q4 | $5.61M | Sell |
391,706
-1,121,935
| -74% | -$16.1M | ﹤0.01% | 2183 |
|
|
2022
Q3 | $38.6M | Buy |
1,513,641
+39,021
| +3% | +$996K | 0.01% | 994 |
|
|
2022
Q2 | $41.9M | Buy |
1,474,620
+246,837
| +20% | +$7.01M | 0.01% | 996 |
|
|
2022
Q1 | $43.3M | Sell |
1,227,783
-112,851
| -8% | -$3.98M | 0.01% | 1060 |
|
|
2021
Q4 | $56.2M | Sell |
1,340,634
-1,803,270
| -57% | -$75.6M | 0.01% | 998 |
|
|
2021
Q3 | $154M | Sell |
3,143,904
-1,042,424
| -25% | -$51.2M | 0.04% | 623 |
|
|
2021
Q2 | $175M | Buy |
4,186,328
+158,590
| +4% | +$6.62M | 0.04% | 595 |
|
|
2021
Q1 | $144M | Buy |
4,027,738
+76,302
| +2% | +$2.72M | 0.04% | 633 |
|
|
2020
Q4 | $111M | Buy |
+3,951,436
| New | +$111M | 0.03% | 687 |
|